COMP <GO>
BEAM vs DNLI // EV/EBITDA & P/E VALUATION
Beam Therapeutics Inc. (NASDAQ) VS. Denali Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: BEAM 4
— DNLI 2
■ METRIC PARITY
LAST: $28.84 (+0.21%) • MKT CAP: $2.98B
valuation
—
LAST: $19.32 (+0.16%) • MKT CAP: $3.09B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BEAM VS. DNLI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BEAM | DNLI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.10% | -35.00% | +2.90 | BEAM | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -12.09% | -13.67% | +1.58 | BEAM | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -57.20% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 120.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.00 | 10.87 | -4.87 | DNLI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | BEAM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.7 | 45.3 | +12.41 | BEAM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.98B | $3.09B | -$109.4M | DNLI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BEAM REV | DNLI REV | BEAM GROSS % | DNLI GROSS % | BEAM FCF | DNLI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $139.7M | $0 | — | — | -$360.0M | -$422.1M |
| FY 2024 | $63.5M | $0 | — | — | -$356.2M | -$363.6M |
| FY 2023 | $377.7M | $330.5M | — | — | -$149.2M | -$358.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BEAM // BETA —
DNLI // BETA —